Fred Confer Iv
About Fred Confer Iv
Fred Confer IV is the Director of the UX + A11Y Center of Excellence at Bristol-Myers Squibb, where he has led significant initiatives in user experience and accessibility.
Current Role at Bristol-Myers Squibb
Fred Confer Iv holds the position of Director at the UX + A11Y Center of Excellence at Bristol-Myers Squibb in Princeton, NJ. In this role, he is responsible for leading initiatives that focus on user experience and accessibility. His efforts include engaging about 20 teams annually, interviewing over 150 users, and delivering more than 750 insights and recommendations for over 20 digital capabilities. He hosted Bristol-Myers Squibb's first Global Accessibility Awareness Day alongside senior executives and Microsoft.
Previous Positions at Bristol-Myers Squibb
Fred Confer Iv has a long tenure at Bristol-Myers Squibb, having served in several key positions. He was the Director of Service Planning from 2012 to 2017, Associate Director of Productivity Management & Continuous Improvement from 2010 to 2012, Clinical Protocol Manager from 2007 to 2010, and Information Technology Project Manager from 2004 to 2007. His roles have spanned various departments including service planning, productivity management, and clinical protocols.
Early Career at Sapient
Before joining Bristol-Myers Squibb, Fred Confer Iv worked at Sapient as the Director of Program Management for seven years, from 1997 to 2004. In this capacity, he was responsible for overseeing program management functions, contributing significantly to the organization's projects and initiatives.
Educational Background
Fred Confer Iv studied Business Administration with a focus on Marketing, achieving a Bachelor of Science (BS) degree between 1988 and 1993. His academic background laid the foundation for his extensive career in program management and user experience leadership.
Key Initiatives and Projects
Fred Confer Iv led the establishment of the BMS ITUX and A11Y Center of Excellence, enhancing user experience and accessibility. He partnered with the Corporate Brand and Diversity & Inclusion organizations to promote awareness of inclusion and accessibility. He also established a team of Tableau Developers and Data Analysts to create dashboards for evaluating UX analytics for the top 70+ applications within the enterprise. Additionally, he implemented unified guidance for user experience and accessibility in major technology initiatives, including clinical trial resources and new commercial technologies like REMS portals for CAR-T and Mavacamten brands.